Business · 04/03/2022
FDA Revokes Two COVID-19 Emergency Use Authorizations
The US Food and Drug Administration (FDA) has revoked two Emergency Use Authorizations (EUAs) for COVID-19 diagnostic devices, issued to Bio-Rad Laboratories and Quotient Suisse SA, due to reasons outlined in the revocation document.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →